Clinical trial
Prophylactic Antipyretic Treatment in Children Receiving Pneumococcal Conjugate…
NCT00370318 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00370318 |
|---|---|
| Title | Prophylactic Antipyretic Treatment in Children Receiving Pneumococcal Conjugate and Standard Infant Vaccines |
| Official title | Multicentre Study to Assess the Effect of Prophylactic Antipyretic Treatment on the Rate of Febrile Reactions Following Concomitant Administration of GSK Biologicals' 10-valent Pneumococcal Conjugate, Infanrix Hexa and Rotarix Vaccines |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Infections, Rotavirus |
| Intervention type | Biological, Drug |
| Interventions | 10 valent pneumococcal conjugate vaccine, Infanrix Hexa, Rotarix, Paracetamol |
| Enrollment | 400 |
| Start date | Sep 1, 2006 |
| Completion | Apr 1, 2007 |
| First posted | Aug 31, 2006 |
| Last update posted | Mar 23, 2017 |
| Countries | Czechia |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: